Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease.

Mykicki, Nadine; Herrmann, Alexander M; Schwab, Nicholas; Deenen, René; Sparwasser, Tim; Limmer, Andreas; Wachsmuth, Lydia; Klotz, Luisa et al. · Sci Transl Med · 2016

basic_science · Level V

Where this comes from

Abstract

In inflammation-associated progressive neuroinflammatory disorders, such as multiple sclerosis (MS), inflammatory infiltrates containing T helper 1 (T<sub>H</sub>1) and T<sub>H</sub>17 cells cause demyelination and neuronal degeneration. Regulatory T cells (T<sub>reg</sub>) control the activation and infiltration of autoreactive T cells into the central nervous system (CNS). In MS and experimental autoimmune encephalomyelitis (EAE) in mice, T<sub>reg</sub> function is impaired. We show that a recently approved drug, Nle<sup>4</sup>-d-Phe<sup>7</sup>-α-melanocyte-stimulating hormone (NDP-MSH), induced functional T<sub>reg</sub>, resulting in amelioration of EAE progression in mice. NDP-MSH also prevented immune cell infiltration into the CNS by restoring the integrity of the blood-brain barrier. NDP-MSH exerted long-lasting neuroprotective effects in mice with EAE and prevented excitotoxic death and reestablished action potential firing in mouse and human neurons in vitro. Neuroprotection by NDP-MSH was mediated via signaling through the melanocortin-1 and orphan nuclear 4 receptors in mouse and human neurons. NDP-MSH may be of benefit in treating neuroinflammatory diseases such as relapsing-remitting MS and related disorders.

Medical subject headings